HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amazon Can Be Liable For Prop 65 Warning Failures, California Appeals Court Says

Executive Summary

Even when it comes to foreign-manufactured cosmetics containing undeclared ingredients listed under California’s Prop 65, online marketplaces the likes of Amazon can be responsible for providing exposure warnings to consumers, according to California’s First Appellate District.

You may also be interested in...

US FDA Warning Letter Salvo: No Such Thing As Approved OTC Skin-Lightening Product

The FDA issued warning letters to a dozen companies about marketing OTC skin-lightening products containing hydroquinone. While the agency’s stance was friendlier toward such products when it launched the OTC drug review program 40 years ago, the program has changed, and so have the FDA’s views on hydroquinone.

High-Mercury Skin Lighteners Remain For Sale As E-commerce Sites Fail To Enforce Policies – NGOs

The Zero Mercury Working Group, an international coalition of NGOs formed in 2005 by the European Environmental Bureau and the Mercury Policy Project, says e-commerce platforms including Amazon and eBay are not doing enough to keep illegal products off their sites, underscoring need for tougher regulations.

FCC To ‘Clarify’ Section 230; FDA On Scented Sanitizers; A Mixed Holiday Shopping Forecast; News In Brief

The Federal Communications Commission intends to “clarify” Section 230 of the Communications Decency Act, suggesting “an overly broad interpretation that in some cases shields social media companies from consumer protection laws” in unintended ways. More news in brief.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts